Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II study demonstrates IRX-4204 to be well tolerated in patients with metastatic CRPC

Feb. 5, 2014

GSK-2140944 shows efficacy in in vitro and in vivo models of infection

Feb. 5, 2014

Tetrandrine demonstrates ability to protect against Ebola virus challenge in vivo

Feb. 4, 2014

Sorafenib activity limited in patients with germ cell tumors

Feb. 4, 2014

Pazopanib demonstrates activity in patients with germ cell tumors

Feb. 4, 2014

Evidence of activity seen with MPX in phase I prostate cancer study

Feb. 3, 2014

Radiotracer [18F]VM-4-037 evaluated in phase II renal cancer study

Feb. 3, 2014

Multiple pivotal phase III trials under way at Array BioPharma

Jan. 31, 2014

Clovis Oncology plans big year for 2014

Jan. 31, 2014

Gilead Sciences details outlook for 2014

Jan. 30, 2014

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...